Aids in the DIAGNOSTIC workup for patients with bcr/abl-positive neoplasms, predominantly chronic myeloid leukemia and acute lymphocytic leukemia.
When positive, the test identifies which mRNA fusion variant is present to guide selection of an appropriate monitoring assay.